Abstract
Deregulation of oncogenic signals in cancer triggers replication stress. Immediate early genes (IEGs) are rapidly and transiently expressed following stressful signals, contributing to an integrated response. Here, we find that the orphan nuclear receptor NR4A1 localizes across the gene body and 3' UTR of IEGs, where it inhibits transcriptional elongation by RNA Pol II, generating R-loops and accessible chromatin domains. Acute replication stress causes immediate dissociation of NR4A1 and a burst of transcriptionally poised IEG expression. Ectopic expression of NR4A1 enhances tumorigenesis by breast cancer cells, while its deletion leads to massive chromosomal instability and proliferative failure, driven by deregulated expression of its IEG target, FOS. Approximately half of breast and other primary cancers exhibit accessible chromatin domains at IEG gene bodies, consistent with this stress-regulatory pathway. Cancers that have retained this mechanism in adapting to oncogenic replication stress may be dependent on NR4A1 for their proliferation.
Keywords:
CTCs; IEGs; R-loops; circulating tumor cells; genomic instability; immediate early genes; orphan nuclear receptor; replication stress; transcriptional regulation.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
3' Untranslated Regions
-
Animals
-
Antineoplastic Agents / pharmacology
-
Binding Sites
-
Breast Neoplasms / drug therapy
-
Breast Neoplasms / genetics
-
Breast Neoplasms / metabolism*
-
Breast Neoplasms / pathology
-
Cell Proliferation* / drug effects
-
Chromatin Assembly and Disassembly
-
Female
-
Gene Expression Regulation, Neoplastic
-
Genomic Instability
-
HEK293 Cells
-
Humans
-
Immediate-Early Proteins / genetics
-
Immediate-Early Proteins / metabolism*
-
Indoles / pharmacology
-
MCF-7 Cells
-
Mice
-
Mice, Inbred NOD
-
Mice, SCID
-
Mitosis* / drug effects
-
Neoplastic Cells, Circulating / drug effects
-
Neoplastic Cells, Circulating / metabolism*
-
Neoplastic Cells, Circulating / pathology
-
Nuclear Receptor Subfamily 4, Group A, Member 1 / antagonists & inhibitors
-
Nuclear Receptor Subfamily 4, Group A, Member 1 / genetics
-
Nuclear Receptor Subfamily 4, Group A, Member 1 / metabolism*
-
Phenylacetates / pharmacology
-
Proto-Oncogene Proteins c-fos / genetics
-
Proto-Oncogene Proteins c-fos / metabolism
-
R-Loop Structures
-
RNA Polymerase II / genetics
-
RNA Polymerase II / metabolism
-
Signal Transduction
-
Transcription Elongation, Genetic
-
Tumor Cells, Cultured
-
Xenograft Model Antitumor Assays
Substances
-
3' Untranslated Regions
-
Antineoplastic Agents
-
FOS protein, human
-
Immediate-Early Proteins
-
Indoles
-
NR4A1 protein, human
-
Nuclear Receptor Subfamily 4, Group A, Member 1
-
Phenylacetates
-
Proto-Oncogene Proteins c-fos
-
p-carboxymethylphenyl 1,1-bis(3'-indolyl)-1-(p-carboxymethylphenyl)methane
-
RNA Polymerase II